Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal

Background: this study was designed to compare the long-term survival outcomes of patients prepared for radioiodine (RAI) therapy using either thyroid hormone withdrawal (THW) or recombinant human thyrotropin (rhTSH) stimulation, by specifically focusing on cases with distant metastases from papilla...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsi-Chen, Ho, Kung-Chu, Chen, Shih-Hsin, Tseng, Jing-Ren, Yang, Lan-Yan, Lin, Kun-Ju, Cheng, Ju-Chin, Liou, Miaw-Jene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775305/
https://www.ncbi.nlm.nih.gov/pubmed/35054388
http://dx.doi.org/10.3390/diagnostics12010221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775305/
https://www.ncbi.nlm.nih.gov/pubmed/35054388
http://dx.doi.org/10.3390/diagnostics12010221

Ejemplares similares